Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2001 2
2002 3
2003 2
2011 1
2013 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Definition of the role of chromosome 9p21 in sporadic melanoma through genetic analysis of primary tumours and their metastases. The Melanoma Cooperative Group.
Palmieri G, Cossu A, Ascierto PA, Botti G, Strazzullo M, Lissia A, Colombino M, Casula M, Floris C, Tanda F, Pirastu M, Castello G; Melanoma Cooperative Group. Palmieri G, et al. Br J Cancer. 2000 Dec;83(12):1707-14. doi: 10.1054/bjoc.2000.1513. Br J Cancer. 2000. PMID: 11104570 Free PMC article.
Early diagnosis of malignant melanoma: Proposal of a working formulation for the management of cutaneous pigmented lesions from the Melanoma Cooperative Group.
Ascierto PA, Palmieri G, Botti G, Satriano RA, Stanganelli I, Bono R, Testori A, Bosco L, Daponte A, Caracò C, Chiofalo MG, Melucci MT, Calignano R, Tatangelo F, Cochran AJ, Castello G; Melanoma Cooperative Group. Ascierto PA, et al. Int J Oncol. 2003 Jun;22(6):1209-15. Int J Oncol. 2003. PMID: 12738985
Two different durations of adjuvant therapy with intermediate-dose interferon alfa-2b in patients with high-risk melanoma (Nordic IFN trial): a randomised phase 3 trial.
Hansson J, Aamdal S, Bastholt L, Brandberg Y, Hernberg M, Nilsson B, Stierner U, von der Maase H; Nordic Melanoma Cooperative Group. Hansson J, et al. Lancet Oncol. 2011 Feb;12(2):144-52. doi: 10.1016/S1470-2045(10)70288-6. Epub 2011 Jan 20. Lancet Oncol. 2011. PMID: 21256809 Clinical Trial.
Mobile hospital rooms to fight melanoma.
Ascierto PA, Caracò C, Ionna F, Pezzullo L, Palmieri G, Melucci MT, Canzanella S; Melanoma Cooperative Group. Ascierto PA, et al. Melanoma Res. 2001 Feb;11(1):83-4. doi: 10.1097/00008390-200102000-00010. Melanoma Res. 2001. PMID: 11254119 No abstract available.
Role functioning before start of adjuvant treatment was an independent prognostic factor for survival and time to failure. A report from the Nordic adjuvant interferon trial for patients with high-risk melanoma.
Brandberg Y, Johansson H, Aamdal S, Bastholt L, Hernberg M, Stierner U, von der Maase H, Hansson J; Nordic Melanoma Cooperative Group. Brandberg Y, et al. Acta Oncol. 2013 Aug;52(6):1086-93. doi: 10.3109/0284186X.2013.789140. Epub 2013 Apr 28. Acta Oncol. 2013. PMID: 23621752 Clinical Trial.
Detection of occult melanoma cells in paraffin-embedded histologically negative sentinel lymph nodes using a reverse transcriptase polymerase chain reaction assay.
Palmieri G, Ascierto PA, Cossu A, Mozzillo N, Motti ML, Satriano SM, Botti G, Caracò C, Celentano E, Satriano RA, Lissia A, Tanda F, Pirastu M, Castello G; Melanoma Cooperative Group. Palmieri G, et al. J Clin Oncol. 2001 Mar 1;19(5):1437-43. doi: 10.1200/JCO.2001.19.5.1437. J Clin Oncol. 2001. PMID: 11230489
Adjuvant therapy of melanoma: what's new?
Ascierto PA, Palmieri G, Daponte A, Melucci MT, Satriano RA, Mozzillo N, Castello G; Melanoma Cooperative Group of Naples. Ascierto PA, et al. Melanoma Res. 2002 Jun;12(3):293-6. doi: 10.1097/00008390-200206000-00015. Melanoma Res. 2002. PMID: 12140388 No abstract available.